Remond A. Fijneman

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Journal: Annals of surgical oncology

Published: January 04, 2026

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 17, 2025

Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets.

Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets.

Journal: Molecular oncology

Published: October 29, 2025

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy.

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy.

Journal: ESMO open

Published: October 02, 2025

BLOODPAC's collaborations with European Union liquid biopsy initiatives.

BLOODPAC's collaborations with European Union liquid biopsy initiatives.

Journal: The journal of liquid biopsy

Published: July 22, 2025

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

Journal: Therapeutic advances in medical oncology

Published: July 08, 2025

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Journal: Annals of surgical oncology

Published: June 30, 2025

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Journal: The British journal of surgery

Published: June 26, 2025

Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.

Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.

Journal: EBioMedicine

Published: April 28, 2025

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

Journal: Nature communications

Published: March 26, 2025

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 24, 2025

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).

Journal: Journal of experimental & clinical cancer research : CR

Published: February 11, 2025

Showing 1-12 of 108

Last Updated: 09/26/2026